151 related articles for article (PubMed ID: 37231800)
1. Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.
Gregg LP; Richardson PA; Herrera MA; Akeroyd JM; Jafry SA; Gobbel GT; Wydermyer S; Arney J; Hung A; Matheny ME; Virani SS; Navaneethan SD
Am J Nephrol; 2023; 54(3-4):126-135. PubMed ID: 37231800
[TBL] [Abstract][Full Text] [Related]
2. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease.
Walther CP; Winkelmayer WC; Richardson PA; Virani SS; Navaneethan SD
Nephrol Dial Transplant; 2021 Sep; 36(10):1893-1899. PubMed ID: 33367872
[TBL] [Abstract][Full Text] [Related]
4. Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors.
Mahmoudpour SH; Asselbergs FW; de Keyser CE; Souverein PC; Hofman A; Stricker BH; de Boer A; Maitland-van der Zee AH
Int J Clin Pharm; 2015 Dec; 37(6):1095-103. PubMed ID: 26159317
[TBL] [Abstract][Full Text] [Related]
5. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
7. Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study.
Arney J; Gregg LP; Wydermyer S; Herrera MA; Richardson PA; Matheny ME; Akeroyd JM; Gobbel GT; Hung A; Virani SS; Navaneethan SD
Cardiorenal Med; 2024; 14(1):34-44. PubMed ID: 38151011
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.
Qiao Y; Shin JI; Sang Y; Inker LA; Secora A; Luo S; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
Mayo Clin Proc; 2019 Nov; 94(11):2220-2229. PubMed ID: 31619367
[TBL] [Abstract][Full Text] [Related]
9. Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci.
Ghouse J; Tragante V; Muhammad A; Ahlberg G; Skov MW; Roden DM; Jonsdottir I; Andreasen L; Lundegaard PR; Trudsø LC; Banasik K; Brunak S; Ostrowski SR; ; Torp-Pedersen C; Pedersen OV; Sørensen E; Køber L; Iversen K; Thorsteinsdottir U; Thorgeirsson G; Ullum H; Gudbjartsson DF; Mosley JD; Holm H; Stefansson K; Bundgaard H; Olesen MS
Eur Heart J; 2022 Dec; 43(45):4707-4718. PubMed ID: 35751511
[TBL] [Abstract][Full Text] [Related]
10. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.
Mahmoudpour SH; Baranova EV; Souverein PC; Asselbergs FW; de Boer A; Maitland-van der Zee AH;
Br J Clin Pharmacol; 2016 Dec; 82(6):1647-1659. PubMed ID: 27524468
[TBL] [Abstract][Full Text] [Related]
11. Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria.
Chienwichai K; Chaloemwa P; Sangkaew S; Chang A
Clin Nephrol; 2024 Jun; 101(6):277-286. PubMed ID: 38606848
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis.
Caldeira D; David C; Sampaio C
Am J Cardiovasc Drugs; 2012 Aug; 12(4):263-77. PubMed ID: 22587776
[TBL] [Abstract][Full Text] [Related]
13. Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports.
Dubrall D; Schmid M; Stingl JC; Sachs B
PLoS One; 2020; 15(3):e0230632. PubMed ID: 32214375
[TBL] [Abstract][Full Text] [Related]
14. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
[TBL] [Abstract][Full Text] [Related]
15. Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study.
de Abajo FJ; Rodríguez-Miguel A; Rodríguez-Martín S; Lerma V; García-Lledó A;
BMC Med; 2021 May; 19(1):118. PubMed ID: 33980231
[TBL] [Abstract][Full Text] [Related]
16. Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature.
Bots SH; Groepenhoff F; Eikendal ALM; Tannenbaum C; Rochon PA; Regitz-Zagrosek V; Miller VM; Day D; Asselbergs FW; den Ruijter HM
JACC Heart Fail; 2019 Mar; 7(3):258-266. PubMed ID: 30819382
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction.
Kane JA; Kim JK; Haidry SA; Salciccioli L; Lazar J
Cardiology; 2017; 137(2):121-125. PubMed ID: 28376504
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactions.
Salim H; Jones AM
Br J Clin Pharmacol; 2022 Nov; 88(11):4812-4827. PubMed ID: 35585835
[TBL] [Abstract][Full Text] [Related]
19. Angioedema related to Angiotensin inhibitors.
Knecht SE; Dunn SP; Macaulay TE
J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
[TBL] [Abstract][Full Text] [Related]
20. Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.
Leon SJ; Whitlock R; Rigatto C; Komenda P; Bohm C; Sucha E; Bota SE; Tuna M; Collister D; Sood M; Tangri N
Am J Kidney Dis; 2022 Aug; 80(2):164-173.e1. PubMed ID: 35085685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
